Congressman Higgins Announces Over $1.34 Million in Recovery Act Funds for Medical Research Projects in Buffalo
Congressman Brian Higgins (NY-27) announced that researchers at Roswell Park Cancer Institute and the University at Buffalo have been awarded $ 1,346,463 in grants made available through Recovery Act funding authorized for the National Institutes of Health (NIH).
“Research dollars are essential in the development of today’s treatments that lead to tomorrow’s cures,” said Congressman Higgins. “These grants provide a significant new investment into the cutting-edge activities happening every day by Roswell Park and UB at Buffalo’s Medical Campus.”
The recent release of Recovery Act funds includes:
- $356,346 for a Roswell research project that will identify novel ways to treat therapy-refractory B cell lymphoma and precisely define how these treatments work;
- $145,399 for a project at Roswell Park Cancer Institute for a study that looks at how parents navigate the health care community after a child is diagnosed with cancer and compare the strategies used;
- $335,208 for Roswell researchers to study of PDEF and survivin as biomarkers to stratify patients with PDEF-/survivin+ tumors and patients with PDEF+/survivin- tumors to aid cancer prognosis’;
- $297,488 for a project at Roswell that seeks to determine the extent that asthma-related pathologies are affected by the enzyme ST6Gal-1 and to evaluate the potential of ST6Gal-1 as a target for drug development;
- $191,544 for a study at UB that tests whether patient race or gender affect immunosuppression drug responses in kidney transplant recipients;
- $20,478 to the University at Buffalo for student and/or teacher summer research at NIH funded labs.
Congressman Higgins has fought long and hard for increased funding to the National Institutes of Health (NIH) and he wrote to Speaker Pelosi last September urging for NIH funding in the Recovery Act bill because it has a stimulative effect on Western New York’s economy.
In a letter sent to Congressional leaders on September 18, 2008 from Higgins and other members of Congress they stressed, “Increasing funding for the NIH this year would also provide a necessary kickstart to our country’s innovation industries, providing economic stimulus that lasts well into the future. Americans understand that more research opportunities into all sorts of diseases will lead to better treatment and cures for the maladies they face…and create America’s next generation of small, entrepreneurial biotechnology firms.”
The Recovery Act included $10.4 billion for the National Institutes of Health, including $8.2 billion for scientific research priorities.